CD4+ cytotoxic T cells: allies and adversaries of aging

CD4+ T cells defy classical immunology classification: while medicine has traditionally viewed them as regulators that orchestrate immune responses via cytokines, recent evidence reveals that some express cytotoxic machinery—perforin and granzymes—similar to their CD8+ and NK cell counterparts. These cytotoxic CD4+ T cells (CD4 CTLs) emerge under chronic antigen exposure, such as persistent viral infections or tumor microenvironments, where they provide an additional layer of immune surveillance; recently, they have been identified as attackers of senescent cells, limiting their accumulation. Yet this same lethal capacity becomes a double-edged sword in aging: their age-related expansion correlates with autoimmune, neurodegenerative, and severe COVID-19 disease. Understanding the precise biology of these cells—their antigen recognition, tissue localization, and effector programs in aged tissues—is critical to explaining why cancer, chronic infections, autoimmunity, and neurodegeneration converge in old age, and opens new therapeutic pathways for the serious biohacker seeking to manipulate immune tolerance without triggering tissue destruction.